Axogen (AXGN) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,687.00 |
| Dec 31, 2025 | -31.00 |
| Sep 30, 2025 | 502.00 |
| Jun 30, 2025 | 3,625.00 |
| Mar 31, 2025 | 2,642.00 |
| Dec 31, 2024 | 2,595.00 |
| Sep 30, 2024 | 1,555.00 |
| Jun 30, 2024 | 2,134.00 |
| Mar 31, 2024 | 2,487.00 |
| Dec 31, 2023 | 1,166.00 |
| Sep 30, 2023 | 724.00 |
| Jun 30, 2023 | 743.00 |
| Mar 31, 2023 | 1,035.00 |
| Dec 31, 2022 | 926.00 |
| Sep 30, 2022 | -345.00 |
| Jun 30, 2022 | -1,401.00 |
| Mar 31, 2022 | -1,157.00 |
| Dec 31, 2021 | 2,580.00 |
| Sep 30, 2021 | -245.00 |
| Jun 30, 2021 | 377.00 |
| Mar 31, 2021 | 2,334.00 |
| Dec 31, 2020 | 2,756.00 |
| Sep 30, 2020 | 3,207.00 |
| Jun 30, 2020 | 1,312.00 |
| Mar 31, 2020 | 3,755.00 |
| Dec 31, 2019 | 9,107.00 |
| Sep 30, 2019 | 4,867.00 |
| Jun 30, 2019 | 6,246.00 |
| Mar 31, 2019 | 9,429.00 |
| Dec 31, 2018 | 11,505.00 |
| Sep 30, 2018 | 10,203.00 |
| Jun 30, 2018 | 9,551.00 |
| Mar 31, 2018 | 13,149.00 |
| Dec 31, 2017 | 17,411.00 |
| Sep 30, 2017 | 10,357.00 |
| Jun 30, 2017 | 4,154.00 |
| Mar 31, 2017 | 10,135.00 |
| Dec 31, 2016 | 11,443.00 |
| Sep 30, 2016 | 28,155.00 |
| Jun 30, 2016 | 13,657.00 |
| Mar 31, 2016 | 19,310.00 |
| Dec 31, 2015 | 33,786.00 |
| Sep 30, 2015 | 12,009.00 |
| Jun 30, 2015 | 703,064.00 |